Oncology
 |
|
14 february 2019 18:00:06 |
| The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy (Nature Reviews Cancer) |
|
Tweet |
| 51 viewsCategory: Oncology |
 Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer (British Journal of Cancer)HAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasis (British Journal of Cancer) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
